Late-life semaglutide treatment slows ageing and extends lifespan in female mice

Semaglutide treatment for 3 months in female mice improved physiological function, attenuated hallmarks of ageing and modulated nutrient sensors and conserved genetic regulators of ageing. Pharmacological glucagon-like peptide-1 receptor (GLP-1R) activation reduces food intake and is an effective therapy for type 2 diabetes and obesity 1 [1].

Sources

1. nature.com · Late-life semaglutide treatment slows ageing and extends lifespan in female mice Sep 2, 2026

This is the neutral brief the press writes once, for everyone, before each reader’s paper adds its own so-what. It links out; it does not republish. 1 article clustered.

Print your own paper